Form 4: ENZB Director Sells All Shares Post-Merger

Enzo Biochem Director Bradley Louis Radoff disposed of all his direct and indirect holdings in the company following its merger with Bethpage Parent, Inc. for $0.70 per share.

Summary

• Bradley Louis Radoff, a Director and 10% Owner of Enzo Biochem Inc. (ENZB), disposed of all his beneficial ownership in the company.
• The disposition occurred on August 20, 2025, pursuant to the Agreement and Plan of Merger dated June 23, 2025.
• Under the merger terms, each share of Enzo Biochem common stock was converted into the right to receive $0.70 in cash.
• Radoff directly disposed of 4,533,779 shares, which included 142,897 Restricted Stock Units (RSUs) and 4,390,882 shares of Common Stock.
• An additional 430,000 shares were indirectly disposed of by The Radoff Family Foundation.
• Following these transactions, Radoff's beneficial ownership in Enzo Biochem Inc. is 0 shares.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing itself is a factual report of a transaction. The merger completion and cash payout are positive for shareholders, but the reporting person's complete exit could be seen as neutral or slightly negative depending on their prior stance.

Positives

• Shareholders received a cash consideration of $0.70 per share, providing liquidity.
• The merger successfully completed, indicating a strategic outcome for the company.

Negatives

• The reporting person no longer holds any shares in the company, indicating a complete exit from their investment in ENZB.

Future Outlook

NA

Industry Context

This filing reflects a common outcome in M&A activities where target company shares are converted into cash, leading to the delisting of the target company's stock and the cessation of beneficial ownership for its former shareholders.

Stakeholder Impact

• Shareholders received a cash payout of $0.70 per share for their holdings.
• The company's common stock is no longer publicly traded as it became a wholly-owned subsidiary of Bethpage Parent, Inc.

Key Dates

Keywords

Enzo Biochem, ENZB, Merger, SEC Form 4, Beneficial Ownership, Stock Disposition, Bradley Louis Radoff, Corporate Action, Cash Consideration, Bethpage Parent